Results 81 to 90 of about 89,794 (164)
High Fructose Consumption and Metabolic Syndrome from Gout Perspective
Uric acid is formed as a consequence of the catabolism of purine nucleotides. The removal of uric acid from the body is mainly carried out by the kidneys via urine and, to a lesser extent, by the intestinal tract via feces.
Ümmühan Fulden Aydın +2 more
core +1 more source
Diastolic and systolic blood pressure and gout: a Mendelian randomization study
Frontiers in EndocrinologyBackgroundAlthough there is solid epidemiological evidence supporting the connection between hypertension and gout, little has been said about the relationship between diastolic and systolic blood pressure and gout, the causal relationship and direction ...
Yanfang Li +13 more
doaj +1 more source
The epidemiology and treatment of gout
, 2011 Neil W McGillInstitute of Rheumatology and Orthopaedics, Royal Prince Alfred Hospital, Camperdown, Sydney, AustraliaAbstract: The development and expression of gout depends on three key steps: (1) chronic hyperuricemia, (2) the growth of monosodium urate
McGill NW
core
Coexisting polyarticular septic arthritis, gout and pseudogout
, 2018 A case of a 67-year-old man with coexisting polyarticular septic arthritis due to group G Streptococcus, gout and pseudogout is presented. Septic arthritis of the left knee joint was further complicated by the development of an adjacent osteomyelitis ...
Colaco, Clinton, Dotel, Ravindra
core +1 more source
Improving adherence to gout therapy: an expert review
, 2018 Fernando Perez-Ruiz,1 Giovambattista Desideri2 1Rheumatology Division, Cruces University Hospital, Baracaldo, Spain; 2Geriatric Unit, Department of Life, Health and Environmental Sciences, University of L’Aquila, L’Aquila, Italy Abstract ...
Desideri G, Perez-Ruiz F
core
Pharmacological treatment of Gout
Gout is a chronic intermittent arthritis that is becoming increasingly prevalent around the world. Gout is caused by the deposition of Monosodium Urate crystals in articular and extra articular locations.
Bar On, Dana
core
Management of hyperuricemia in gout: focus on febuxostat
, 2010 Mattheus K Reinders1, Tim L Th A Jansen21Clinical Pharmacy, Atrium Medisch Centrum Parkstad, Heerlen, The Netherlands; 2Rheumatology, Medisch Centrum Leeuwarden, Leeuwarden, The NetherlandsAbstract: Gout is the most common inflammatory arthritis in an ...
Tim L Th A Jansen, Mattheus K Reinders
core
Atypical musculoskeletal manifestations of gout in hyperuricemia patients
, 2019 Muhammad Sakti, Muhammad Andry Usman, Jansen Lee, Michael Benjamin, Qariah Maulidiah Department of Orthopaedic and Traumatology, Hasanuddin University Teaching Hospital, Makassar, Indonesia Abstract: Deposition of tophus is a common feature in chronic ...
Maulidiah Q +4 more
core
The association between thyroid disorders and incident gout: population-based case–control study
, 2017 Saskia G Bruderer,1,2 Christoph R Meier,1–3 Susan S Jick,3 Michael Bodmer1,4 1Basel Pharmacoepidemiology Unit, Division of Clinical Pharmacy and Epidemiology, Department of Pharmaceutical Sciences, University of Basel, 2Hospital Pharmacy ...
Meier CR, Bruderer SG, Bodmer M, Jick SS
core
DcR3 suppresses the NF-κB pathway and the NLRP3 inflammasome activation in gouty inflammation
Chinese Medical JournalYi Jiang +9 more
doaj +1 more source